Clinical Trials Directory

Trials / Completed

CompletedNCT05450848

StrataXRT vs. Standard Clinical Practice in the Prevention and Treatment of Radiation Dermatitis

A Randomised Comparison of StrataXRT to Standard Clinical Practice in the Prevention and Treatment of Radiation Dermatitis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
105 (actual)
Sponsor
Stratpharma AG · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Current clinical practice for preventing and treating radiation dermatitis across Queensland (QLD) Health Radiation Oncology departments involves the application of aqueous cream daily to the skin of the treatment site, commencing from Day 1 of EBRT. The primary aim of this study is to assess the efficacy of StrataXRT when compared to current clinical practice in preventing and managing radiation dermatitis.

Conditions

Interventions

TypeNameDescription
DEVICEStrataXRTStrataXRT is a flexible wound dressing for the prevention and treatment of radiation dermatitis. It is in the form of a gel which, when applied, creates a protective film that maintains skin integrity. The product is used to relieve low grade inflammatory radiation changes such as dry, itching, flaking, peeling and irritated skin. For more severe inflammatory changes with open wound components, StrataXRT reduces pain, redness and heat and helps soothe the exposed skin areas. StrataXRT can be applied where skin integrity has been compromised and may also be used in conjunction with other adjunctive treatments to improve overall results. StrataXRT contains Polydimethylsiloxanes, Siloxanes and Alkylmethyl Silicones and is transparent and odourless. It does not contain alcohols, parabens or fragrances. StrataXRT can be used with or without a secondary protective dressing. It is suitable for children and people with sensitive skin.
OTHERSorboleneAqueous cream (moisturizer) that soothes itchiness and dryness of the skin, and aids skin hydration. It is non-greasy, fragrance free, colour free, GMO free, paraben free and pH balanced.

Timeline

Start date
2017-09-01
Primary completion
2023-03-31
Completion
2023-03-31
First posted
2022-07-11
Last updated
2023-07-12

Locations

2 sites across 1 country: Australia

Source: ClinicalTrials.gov record NCT05450848. Inclusion in this directory is not an endorsement.